FEBS Letters
Retraction Statement: MiR‐449c targets c‐Myc and inhibits NSCLC cell progression
FEBS Letters, Volume 596, Issue 11, Page 1481-1481, June 2022.
FEBS Letters
Biophysical characterization as a tool to predict amyloidogenic and toxic properties of amyloid‐β42 peptides
FEBS Letters, Volume 596, Issue 11, Page 1401-1411, June 2022.
FEBS Letters
The degree of unsaturation of fatty acids in phosphatidylserine alters the rate of insulin aggregation and the structure and toxicity of amyloid aggregates
FEBS Letters, Volume 596, Issue 11, Page 1424-1433, June 2022.
FEBS Letters
Crystal structures of human glyoxalase I and its complex with TLSC702 reveal inhibitor binding mode and substrate preference
FEBS Letters, Volume 596, Issue 11, Page 1458-1467, June 2022.
FEBS Letters
Adipocyte‐specific CDK7 ablation leads to progressive loss of adipose tissue and metabolic dysfunction
FEBS Letters, Volume 596, Issue 11, Page 1434-1444, June 2022.
FEBS Letters
Arginyl‐tRNA‐protein transferase 1 (ATE1) promotes melanoma cell growth and migration
FEBS Letters, Volume 596, Issue 11, Page 1468-1480, June 2022.
FEBS Letters
Long noncoding RNAs in cardiometabolic disorders
FEBS Letters, Volume 596, Issue 11, Page 1367-1387, June 2022.
FEBS Letters
How to tame your genes: mechanisms of inflammatory gene repression by glucocorticoids
FEBS Letters, Volume 596, Issue 20, Page 2596-2616, October 2022.
FEBS Letters
Endomembrane‐mediated storage protein trafficking in plants: Golgi‐dependent or Golgi‐independent?
FEBS Letters, Volume 596, Issue 17, Page 2215-2230, September 2022.
FEBS Letters
Retraction Statement: The circadian rhythm regulator RpaA modulates photosynthetic electron transport and alters the preferable temperature range for growth in a cyanobacterium
FEBS Letters, Volume 596, Issue 15, Page 1969-1969, August 2022.